SCHEMBL6999829

SCHEMBL6999829

OC1(c2ccc3[nH]cc(C4CCN5CCCC5C4)c3c2)CCCCC1

nearest known ligand 0.54

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SLC6A4 P31645 9/20 0.54
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C9 P11712 1/20 0.41
THPO P40225 1/20 0.41
OPRM1 P35372 1/20 0.41
OPRK1 P41145 1/20 0.41
OPRL1 P41146 1/20 0.41
HSD11B1 P28845 3/20 0.41
HTR1B P28222 2/20 0.39
HTR1D P28221 1/20 0.39
MTNR1A P48039 1/20 0.37
MTNR1B P49286 1/20 0.37
HTR1A P08908 1/20 0.37
DRD1 P21728 1/20 0.37
SLC6A2 P23975 1/20 0.37
HTR2A P28223 1/20 0.37
SLC6A3 Q01959 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8381443 0.81 CYP1A2 (0.63) SLC6A4CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL6995996 0.79 SLC6A4 (0.59) SLC6A4CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL7011235 0.78 SLC6A4 (0.84) SLC6A4OPRM1OPRK1OPRL1HSD11B1
SCHEMBL6996942 0.78 SLC6A4 (0.61) SLC6A4CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL6642008 0.78 HTR1D (0.63) SLC6A4CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL7006323 0.78 CYP1A2 (0.55) CYP1A2CYP3A4CYP2D6CYP2C9THPO
SCHEMBL7014120 0.76 SLC6A4 (0.56) SLC6A4CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL7014117 0.76 SLC6A4 (0.56) SLC6A4CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL6997701 0.76 HTR1D (0.57) SLC6A4CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL7002497 0.76 SLC6A4 (0.61) SLC6A4CYP1A2CYP3A4CYP2D6CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6562809-B1 Contraction of coronary arteries may be mediated by its stimulation of the 5-HT1B (formerly 5-HT1D beta); compounds selective for a 5-HT1D receptor NPS ALLELIX CORP. (CA) 2003-05-13 US claimed
EP-1114049-B1 3-BICYCLOINDOLE COMPOUNDS AS 5-HT1D RECEPTOR LIGANDS NPS ALLELIX CORP (CA) 2003-03-19 EP claimed
EP-1114049-B1 3-BICYCLOINDOLE COMPOUNDS AS 5-HT1D RECEPTOR LIGANDS NPS ALLELIX CORP (CA) 2003-03-19 EP disclosed
EP-1114049-A1 3-BICYCLOINDOLE COMPOUNDS AS 5-HT1D RECEPTOR LIGANDS NPS Allelix Corp. (CA) 2001-07-11 EP disclosed
WO-2000017198-A1 3-BICYCLOINDOLE COMPOUNDS AS 5-HT1D LIGANDS ALLELIX BIOPHARMACEUTICALS INC. (CA) 2000-03-30 WO disclosed